Comparison of postoperative pain for 0.5% hyperbaric bupivacaine given as spinal block with intravenous or spinal dexmedetomidine in abdominal hysterectomy.
Not yet recruiting
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2022/05/042588
- Lead Sponsor
- JLN medical college and hospital
- Brief Summary
The aim of our study is compare of intravenous and intrathecal dexmedetomidine as adjuvants to 0.5% hyperbaric bupivacaine in abdominal hysterectomy with respect to
PRIMARY OBJECTIVE : Duration of post operative analgesia
SECONDARY OBJECTIVES : Onset and recovery of sensory block, onset or recovery of motor block, peri operative sedation score,haemodyanamic changes, adverse effect if any.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- 1.body weight 40 to 80 kg.
- 2.Patient belonging to ASA class I and II.
- 3.Patient undergoing abdominal surgery.
Exclusion Criteria
- 1.Patient refusal or uncooperative patient.
- 2.Any known hypersensitivity or contraindication to bupivacaine, dexmedetomidine.
- 3.Local pathology at the site of injection or disability limiting the performance of spinal block.
- History of convulsion, bleeding disorder, severe neurological deficit, thyroid disorder.
- Patient with history of respiratory,cardiac,hepatic or renal disease.
- Patient having a history of significant neurological,psychiatric or neuromuscular disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of analgesia. 1 year
- Secondary Outcome Measures
Name Time Method Onset and recovery(time to 2 segment regression) of sensory block. Onset and recovery of motor block,
Trial Locations
- Locations (1)
J.L.N medical college and hospital
🇮🇳Ajmer, RAJASTHAN, India
J.L.N medical college and hospital🇮🇳Ajmer, RAJASTHAN, IndiaDr Durga lal yadavPrincipal investigator9252255176drdly10@gmail.com